Skip to main content
Digital Seminar

Psychopharmacology: Essential Information for Mental Health Professionals


Faculty:
Kenneth Carter, PhD, ABPP
Duration:
6 Hours 18 Minutes
Format:
Audio and Video
Copyright:
Jun 03, 2021
Product Code:
POS054845
Media Type:
Digital Seminar
Access:
Never expires.


Description

Dr. Kenneth Carter, a board certified clinical psychologist with a Master’s degree in clinical psychopharmacology, shares his clinical experience and training to provide detailed information about the range of common medications prescribed for mental health conditions. You will get the latest information on antidepressants, anxiolytics, and common medications for insomnia and Attention Deficit/Hyperactivity Disorder among others. Through lecture, the examination of multi-disciplinary ethics codes and real case examples, you will take a close look at the ethical decisions that accompany medication use and the non-prescriber's role and limits with regards to medication discussions with your patients.

Dr. Carter answers questions from providers in the field and walks through examples of practical clinical discussions that come up every day in practice, including how to discuss scope of practice with your patients in order to optimize their care when working with multiple providers. The goal is for you to leave better prepared to communicate with your clients as well as the prescribers, as Dr. Carter instructs you on how the medications work, their benefits, and the side effects and dangerous reactions associated with them.

CPD


CPD
- PESI Australia, in collaboration with PESI in the USA, offers quality online continuing professional development events from the leaders in the field at a standard recognized by professional associations including psychology, social work, occupational therapy, alcohol and drug professionals, counselling and psychotherapy. On completion of the training, a Professional Development Certificate is issued after the individual has answered and submitted a quiz and course evaluation. This online program is worth 6.5 hours CPD for points calculation by your association.

Handouts

Faculty

Kenneth Carter, PhD, ABPP's Profile

Kenneth Carter, PhD, ABPP Related seminars and products


Kenneth Carter, PhD, ABPP, is a board-certified clinical psychologist and professor of psychology at Oxford College of Emory University in Atlanta, Georgia. Dr. Carter received his MA and PhD in clinical psychology from the University of Michigan in Ann Arbor and a postdoctoral master's degree in clinical psychopharmacology from Fairleigh Dickerson University. Dr. Carter has taught clinical psychopharmacology classes at Emory University since 2005 and has presented highly rated psychopharmacology workshops to clinicians throughout the United States since 2010. Dr. Carter has served as a senior assistant research scientist in the Epidemic Intelligence Service of the Centers for Disease Control and Prevention. He has been a psychotherapist and researcher for more than 20 years, during which time he has garnered awards from the National Institutes of Health, the National Heart, Lung and Blood Institute, and the University of Michigan. Dr. Carter has presented at numerous conferences and written several books and articles on introductory psychology, neuropsychology and psychopharmacology.

 

Speaker Disclosures:

Financial: Dr. Kenneth Carter has employment relationships with Positive Impact Health Centers and Oxford College of Emory University. He is a published author and receives royalties. Dr. Carter receives a speaking honorarium and recording royalties from PESI, Inc. He has no relevant financial relationships with ineligible organizations.

Non-financial: Dr. Kenneth Carter is a member of the American Psychological Association, the Association for Psychological Science, the Neuroscience Education Institute, the American Association for the Advancement of Pharmocotherapy, and the American Board of Professional Psychology.


Objectives

  1. Discuss the proper role of mental health professionals who treat clients receiving both psychotherapeutic medications and psychotherapy.
  2. Describe specific ethical issues and resolutions related to communicating with clients and prescribing professionals about psychotropic medications.
  3. Explain the neurotransmitter systems and neuroanatomy underlying the biological basis for mental disorders and pharmacotherapy.
  4. Identify the major classes of drugs used to treat mental disorders and which mental disorders are appropriately treated with each class of drugs.
  5. Describe adverse effects and drug reactions of the commonly prescribed psychotropic medications and when to alert the prescriber about them.
  6. Analyze the role that half-life plays in the efficacy of insomnia medications prescribed for clients and how it may affect behavioural interventions.

Outline

MEDS 101
  • Case study
  • Reasons to be knowledgeable about psychiatric medications
  • Lessons from other disciplines
  • Pharmacy
  • Nursing
  • Ethics guidelines
  • The common questions clients have about their medications
  • Handling differences of opinion between yourself and a prescribing professional
GENERAL OVERVIEW OF THE NERVOUS SYSTEM
  • Organization of the nervous system
  • Structure of the neuron
  • Communication between neurons
  • How medicines interact with the nervous system
DEPRESSION MEDICATIONS
  • Neurobiology
  • SSRIs and SNRIs
  • Mechanism of action
  • Benefits and adverse reactions
  • Medications in these categories
  • Case Study
ANXIETY DISORDER MEDICATIONS
  • DSM-5® anxiety categories
  • Deconstructionist approach taken by prescribers
  • Neurobiology
  • SRRIs and Benzodiazepines
  • Mechanism of action
  • Benefits and adverse reactions
  • Medications in these categories
  • Case study
BIPOLAR MEDICATIONS
  • Monotherapy
  • Lithium, anticonvulsants, and 2nd generation antipsychotics
  • Mechanism of action
  • Benefits and adverse reactions
  • Medications in these categories
  • Case study
ADHD MEDICATIONS
  • Neurobiology
  • Methylphenidate and amphetamine
  • Mechanism of action
  • Delivery systems
  • Benefits and adverse reactions
  • Medications in these categories
  • Case study
ANTIPSYCHOTIC MEDICATIONS
  • Psychosis symptoms
  • Neurobiology
  • 1st and 2nd generation
  • Antipsychotics
  • Mechanism of action
  • Benefits and adverse reactions
  • Medications in these categories
  • Case study
INSOMNIA MEDICATIONS
  • Causes and treatments for insomnia
  • Medications for insomnia
  • Half-life
  • Benefits and adverse reactions
  • Case study
LIMITATIONS OF THE RESEARCH & POTENTIAL RISKS

Target Audience

  • Counselors
  • Social Workers
  • Psychologists
  • Psychotherapists
  • Case Managers
  • Marriage & Family Therapists
  • Nurses
  • Nurse Practitioners
  • Clinical Nurse Specialists
  • Addiction Counselors
  • Pharmacists
  • Occupational Therapists
  • Occupational Therapy Assistants
  • Other Mental Health & Healthcare Professionals

Please wait ...

Back to Top